Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
<p>Abstract</p> <p>Background</p> <p>Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the e...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-11-01
|
| Series: | BMC Nephrology |
| Online Access: | http://www.biomedcentral.com/1471-2369/11/29 |